FULC
Price
$4.46
Change
+$0.10 (+2.30%)
Updated
Dec 23, 10:38 AM (EDT)
66 days until earnings call
SLS
Price
$0.93
Change
+$0.04 (+4.49%)
Updated
Dec 23, 10:58 AM (EDT)
87 days until earnings call
Ad is loading...

FULC vs SLS

Header iconFULC vs SLS Comparison
Open Charts FULC vs SLSBanner chart's image
Fulcrum Therapeutics
Price$4.46
Change+$0.10 (+2.30%)
Volume$3K
CapitalizationN/A
SELLAS Life Sciences Group
Price$0.93
Change+$0.04 (+4.49%)
Volume$6.25K
CapitalizationN/A
FULC vs SLS Comparison Chart
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. SLS commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Hold and SLS is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (FULC: $4.35 vs. SLS: $0.89)
Brand notoriety: FULC and SLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 362% vs. SLS: 105%
Market capitalization -- FULC: $235.44M vs. SLS: $63.39M
FULC [@Biotechnology] is valued at $235.44M. SLS’s [@Biotechnology] market capitalization is $63.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileSLS’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • SLS’s FA Score: 0 green, 5 red.
According to our system of comparison, FULC is a better buy in the long-term than SLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 6 TA indicator(s) are bullish while SLS’s TA Score has 4 bullish TA indicator(s).

  • FULC’s TA Score: 6 bullish, 4 bearish.
  • SLS’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, FULC is a better buy in the short-term than SLS.

Price Growth

FULC (@Biotechnology) experienced а +9.85% price change this week, while SLS (@Biotechnology) price change was +1.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

FULC is expected to report earnings on Feb 27, 2025.

SLS is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($235M) has a higher market cap than SLS($63.4M). SLS YTD gains are higher at: -16.226 vs. FULC (-35.556). FULC has higher annual earnings (EBITDA): -26.67M vs. SLS (-32.77M). FULC has more cash in the bank: 257M vs. SLS (21M). SLS has less debt than FULC: SLS (576K) vs FULC (9.15M). FULC has higher revenues than SLS: FULC (80.9M) vs SLS (0).
FULCSLSFULC / SLS
Capitalization235M63.4M371%
EBITDA-26.67M-32.77M81%
Gain YTD-35.556-16.226219%
P/E RatioN/AN/A-
Revenue80.9M0-
Total Cash257M21M1,224%
Total Debt9.15M576K1,588%
FUNDAMENTALS RATINGS
SLS: Fundamental Ratings
SLS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FULCSLS
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
87%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
View a ticker or compare two or three
Ad is loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MU90.123.03
+3.48%
Micron Technology
RYAN64.010.86
+1.36%
Ryan Specialty Holdings
RES5.63-0.02
-0.35%
RPC
ZH3.60-0.03
-0.83%
Zhihu
PDSB1.65-0.10
-5.71%
PDS Biotechnology Corp

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ONCT. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ONCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+7.94%
ONCT - FULC
55%
Loosely correlated
N/A
SLS - FULC
48%
Loosely correlated
-1.11%
ANNX - FULC
40%
Loosely correlated
+0.19%
VRDN - FULC
39%
Loosely correlated
+1.60%
MLTX - FULC
34%
Loosely correlated
+0.56%
More